Bavarian Nordic A/S
BAVA
Peringkat dalam Saham
#5045
Hellerup, Denmark-based Bavarian Nordic A/S, founded in 1992, specializes in... Hellerup, Denmark-based Bavarian Nordic A/S, founded in 1992, specializes in the research, production, and global distribution of vital, life-saving vaccines. The company's commercialized offerings include non-replicating vaccines for smallpox and monkeypox, marketed as IMVAMUNE, IMVANEX, and JYNNEOS. Additionally, their portfolio features Rabipur/RabAvert for rabies prevention, Encepur for tick-borne encephalitis, and MVABEA, an Ebola vaccine. Bavarian Nordic also maintains a robust pipeline of investigational treatments. This includes MVA-BN (freeze-dried), which has successfully completed Phase III clinical trials for smallpox; MVA-BN RSV, currently in Phase III development for respiratory syncytial virus; ABNCoV2, which completed Phase II trials targeting SARS-CoV-2; and TAEK-VAC, presently in Phase I/II trials for advanced HER2 and brachyury-expressing cancers. The firm engages in key partnerships, notably a license and collaboration agreement with AdaptVac, and licensing agreements with both the National Cancer Institute and the Public Health Service. Bavarian Nordic operates across a wide international footprint, with a presence in countries such as the United States, Germany, Belgium, France, Canada, the United Kingdom, Hong Kong, Saudi Arabia, Australia, Switzerland, and numerous other global markets.
Harga Saham
$37.69
Kapitalisasi Pasar
$2.86B
Perubahan (1 hari)
-0.17%
Perubahan (1 tahun)
1.27%
Negara
DK
Perdagangan Bavarian Nordic A/S (BAVA)
Kategori
Healthcare
Kapitalisasi pasar dari Bavarian Nordic A/S(BAVA)
Kapitalisasi Pasar: $2.86B
Per October 2026, Bavarian Nordic A/S memiliki kapitalisasi pasar sebesar $2.86B. Ini menjadikan Bavarian Nordic A/S sebagai perusahaan 5045th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Bavarian Nordic A/S dari 2003 hingga 2026
BAVA dibandingkan dengan 5 teratas stocks paling populer
